β-Amyloid Accumulation Slows Earlier than Expected in Preclinical Alzheimer's Disease Patients
- PMID: 30355622
- PMCID: PMC6705993
- DOI: 10.1523/JNEUROSCI.1592-18.2018
β-Amyloid Accumulation Slows Earlier than Expected in Preclinical Alzheimer's Disease Patients
Comment on
-
Subthreshold Amyloid Predicts Tau Deposition in Aging.J Neurosci. 2018 May 9;38(19):4482-4489. doi: 10.1523/JNEUROSCI.0485-18.2018. Epub 2018 Apr 23. J Neurosci. 2018. PMID: 29686045 Free PMC article.
Similar articles
-
Alzheimer's disease: where next for anti-amyloid therapies?Brain. 2017 Apr 1;140(4):853-855. doi: 10.1093/brain/awx059. Brain. 2017. PMID: 28375461 No abstract available.
-
Multifunctional molecules with a bipyridyl core ameliorate multifaceted amyloid toxicity.Chem Commun (Camb). 2022 May 26;58(43):6288-6291. doi: 10.1039/d2cc01168a. Chem Commun (Camb). 2022. PMID: 35537119
-
How our bodies fight amyloidosis: effects of physiological factors on pathogenic aggregation of amyloidogenic proteins.Arch Biochem Biophys. 2015 Feb 15;568:46-55. doi: 10.1016/j.abb.2015.01.007. Epub 2015 Jan 20. Arch Biochem Biophys. 2015. PMID: 25615529 Review.
-
Exogenous amyloidogenic proteins function as seeds in amyloid β-protein aggregation.Biochim Biophys Acta. 2014 Apr;1842(4):646-53. doi: 10.1016/j.bbadis.2014.01.002. Epub 2014 Jan 14. Biochim Biophys Acta. 2014. PMID: 24440525
-
Alzheimer's disease and the amyloid beta protein: What is the role of amyloid?J Neurochem. 1999 Aug;73(2):443-9. doi: 10.1046/j.1471-4159.1999.0730443.x. J Neurochem. 1999. PMID: 10428038 Review. No abstract available.
Cited by
-
Human iPSC-Derived Neural Models for Studying Alzheimer's Disease: from Neural Stem Cells to Cerebral Organoids.Stem Cell Rev Rep. 2022 Feb;18(2):792-820. doi: 10.1007/s12015-021-10254-3. Epub 2022 Feb 2. Stem Cell Rev Rep. 2022. PMID: 35107767 Free PMC article. Review.
-
Astrocytes respond to a neurotoxic Aβ fragment with state-dependent Ca2+ alteration and multiphasic transmitter release.Acta Neuropathol Commun. 2021 Mar 16;9(1):44. doi: 10.1186/s40478-021-01146-1. Acta Neuropathol Commun. 2021. PMID: 33726852 Free PMC article.
-
Glycan Mimetics from Natural Products: New Therapeutic Opportunities for Neurodegenerative Disease.Molecules. 2019 Dec 16;24(24):4604. doi: 10.3390/molecules24244604. Molecules. 2019. PMID: 31888221 Free PMC article. Review.
-
Association Between Polygenic Risk Score and the Progression from Mild Cognitive Impairment to Alzheimer's Disease.J Alzheimers Dis. 2021;84(3):1323-1335. doi: 10.3233/JAD-210700. J Alzheimers Dis. 2021. PMID: 34657885 Free PMC article.
-
More than anti-malarial agents: therapeutic potential of artemisinins in neurodegeneration.Neural Regen Res. 2019 Sep;14(9):1494-1498. doi: 10.4103/1673-5374.255960. Neural Regen Res. 2019. PMID: 31089038 Free PMC article. Review.
References
-
- Bennett RE, Robbins AB, Hu M, Cao X, Betensky RA, Clark T, Das S, Hyman BT (2018) Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease. Proc Natl Acad Sci U S A 115:E1289–E1298. 10.1073/pnas.1710329115 - DOI - PMC - PubMed
-
- Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, Finch CE, Krafft GA, Klein WL (2003) Alzheimer's disease-affected brain: presence of oligomeric A ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci U S A 100:10417–10422. 10.1073/pnas.1834302100 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical